Functional Interplay of Type-2 Corticotrophin Releasing Factor and Dopamine Receptors in the Basolateral Amygdala-Medial Prefrontal Cortex Circuitry

dc.contributor.authorYarur, H. E.
dc.contributor.authorZegers, J.
dc.contributor.authorVega Quiroga, I.
dc.contributor.authorNovoa, J.
dc.contributor.authorCiruela Alférez, Francisco
dc.contributor.authorAndres, M. E.
dc.contributor.authorGysling, K.
dc.date.accessioned2021-05-27T09:39:37Z
dc.date.available2021-05-27T09:39:37Z
dc.date.issued2020-10-30
dc.date.updated2021-05-26T15:44:43Z
dc.description.abstractBackground: Basolateral amygdala (BLA) excitatory projections to medial prefrontal cortex (PFC) play a key role controlling stress behavior, pain, and fear. Indeed, stressful events block synaptic plasticity at the BLA-PFC circuit. The stress responses involve the action of corticotrophin releasing factor (CRF) through type 1 and type 2 CRF receptors (CRF1 and CRF2). Interestingly, it has been described that dopamine receptor 1 (D1R) and CRF peptide have a modulatory role of BLA-PFC transmission. However, the participation of CRF1 and CRF2 receptors in BLA-PFC synaptic transmission still is unclear. Methods: We used in vivo microdialysis to determine dopamine and glutamate (GLU) extracellular levels in PFC after BLA stimulation. Immunofluorescence anatomical studies in rat PFC synaptosomes devoid of postsynaptic elements were performed to determine the presence of D1R and CRF2 receptors in synaptical nerve endings. Results: Here, we provide direct evidence of the opposite role that CRF receptors exert over dopamine extracellular levels in the PFC. We also show that D1R colocalizes with CRF2 receptors in PFC nerve terminals. Intra-PFC infusion of antisauvagine-30, a CRF2 receptor antagonist, increased PFC GLU extracellular levels induced by BLA activation. Interestingly, the increase in GLU release observed in the presence of antisauvagine-30 was significantly reduced by incubation with SCH23390, a D1R antagonist. Conclusion: PFC CRF2 receptor unmasks D1R effect over glutamatergic transmission of the BLA-PFC circuit. Overall, CRF2 receptor emerges as a new modulator of BLA to PFC glutamatergic transmission, thus playing a potential role in emotional disorders. Keywords: CRF2 receptor; D1 receptor; dopaminergic transmission; glutamatergic transmission; prefrontal cortex.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid33125479
dc.identifier.urihttps://hdl.handle.net/2445/177706
dc.language.isoeng
dc.publisherOxford University Press
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1093/ijnp/pyaa079
dc.relation.ispartofInternational Journal of Neuropsychopharmacology, 2020, vol. 24, num. 3, p. 221-228
dc.relation.urihttps://doi.org/10.1093/ijnp/pyaa079
dc.rightscc by-nc (c) Yarur et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationCos amigdaloide
dc.subject.classificationDopamina
dc.subject.otherAmygdaloid body
dc.subject.otherDopamine
dc.titleFunctional Interplay of Type-2 Corticotrophin Releasing Factor and Dopamine Receptors in the Basolateral Amygdala-Medial Prefrontal Cortex Circuitry
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
pyaa079.pdf
Mida:
10.38 MB
Format:
Adobe Portable Document Format